Delta: HealthTech Innovators

It is important for HealthTech startups to know that a single CYBERSECURITY attack in the healthcare sector can cost businesses approximately $10.1 million. Many HealthTech startups that are innovating in this space are required and obligated to adhere to standards such as HIPAA and SOC2Failing to implement robust security standards and experiencing breaches in patient information can severely impact even the most successful unicorn companies, leading to significant devaluation.Today's guest is Justin Beals, the CEO Strike Graph, a comprehensive platform designed to empower companies and healthtech startups with the necessary tools for creating, managing, and evaluating a strong compliance program.This platform focuses on enhancing customer confidence which, in turn, can significantly increase revenue and facilitate smoother integration within the healthcare sector.This episode is brought to you by Mesh Ai:https://welcome.meshai.io/For sponsoring future episodes, please email us at roupen@deltahealth.techTime stamps:00:00 - Introduction02:25 - Introduction to Striking Graph03:26 - Understanding HIPAA Compliance03:46 - Exploring SOC 2 Compliance07:17 - GDPR Explained09:30 - ISO 27001 Overview10:50 - HITRUST Certification Discussion12:16 - Innovation in Healthcare: Compliance Differences Between SaaS and Medical Devices14:20 - Timeline and Requirements for Achieving HITRUST Certification16:35 - Estimating Costs for HIPAA and SOC 2 Compliance18:10 - Common Pitfalls in Scaling Compliance Programs23:21 - Ensuring System Security Post-Compliance Implementation31:35 - Strike Graph's Role in Enhancing Healthcare Security Compliance33:31 - Advice for Health Tech Startups at the Beginning of Their JourneyWatch on YouTube: https://youtu.be/6HGzrYBnTvgRoupen Odabashian:LinkedIn: https://www.linkedin.com/in/roupen-odabashian-183aaa142/X: https://twitter.com/RoupenMDFor sponsorships please Email: roupen@deltahealth.tech:Justin Beals:LinkedIn: https://www.linkedin.com/in/jubeals/Strike Graph:Website: https://www.strikegraph.com/LinkedIn: https://www.linkedin.com/company/strikegraph/HealthTech Cybersecurity startup, healthcare tech startups, health tech startups, health tech companies, healthercare tech startups

There is an increasing complexity of clinical decision-making in Healthcare. In response to this challenge, AvoMD a healthtech startup has developed a point-of-care application specifically designed to assist physicians in systematizing clinical decision-making. The app aligns with the latest guidelines and protocols from the hospitals or clinics where physicians practice, offering a streamlined and individualized approach to patient care. AvoMD not only facilitates the decision-making process by providing immediate access to relevant guidelines and risk calculators but also enables real-time documentation of the clinical decisions as they are made. Today's guest is Dr Saperstein, an accomplished physician entrepreneur with an interesting background, that combines both, medicine and tech who took the lead to improve healthcare for the benefit of many people. This episode is brought to you by Mesh AI:https://welcome.meshai.io/ For sponsoring future episodes, please email us at roupen@deltahealth.tech Time stamps:1:18 - The start of AvoMD12:47 - Showcasing AvoMD's Impact13:08 - Demystifying "No Code" for the Everyday Physician15:21 - Securing the First AvoMD First Customer17:03 - The Imperative of Customization in Healthcare Solutions21:59 - Exploring AvoMD's Broader ROI: Beyond Time Savings28:41 - Embracing the "Fail Fast" Philosophy in HealthTech Innovation35:26 - Navigating the Fundraising Landscape for Health Tech Ventures37:07 - Merging Paths: The Intersection of Entrepreneurship and Medicine39:11 - Reflecting on the Most Rewarding Facets of the AvoMD Journey41:42 - The Art of Team Building: Insights on Hiring and Firing Roupen Odabashian:LinkedIn: https://www.linkedin.com/in/roupen-odabashian-183aaa142/X: https://twitter.com/RoupenMDFor sponsorships please Email: roupen@deltahealth.tech Yair Saperstein, MD MPHLinkedIn: https://www.linkedin.com/in/yair-saperstein/AvoMD:Website: https://www.avomd.io/LinkedIn: https://www.linkedin.com/company/avomd/

How can we revolutionize asthma care beyond the use of inhalers? What monitoring options are available that help patients monitor their condition and take preventive measures before needing to go to the hospital?Today, we will talk about Keva Health, a company formed when the founders' daughter was diagnosed with asthma at the age of 3. Keva Health is a pioneering company that provides solutions to assist with monitoring and improving health outcomes for asthma patients by offering real-time feedback, enabling them to monitor their condition closely. Beyond that, it helps healthcare providers to monitor their patients effectively. Join me today as we talk to Jyotsna Mehta, the founder of Keva Health.  This Episode is brought to you by MeshAI   MeshAI is a scheduling software for healthcare workers, including medical students, residents, physicians, and nurses, it alleviates administrative burdens by leveraging AI algorithms for scheduling shifts.   Website: https://welcome.meshai.io  For sponsoring future episodes, please email us at roupen@deltahealth.tech  Time stamps:  2:06 - The Start of Kava Health 5:50 - Kava Health Technology 9:58 - Downloading and Using the App 14:07 - Associated Medical Devices 16:18 - Alert System for Patients 21:59 - Ensuring Patient Adherence 25:40 - Overcoming Healthcare Challenges 27:59 - Acquiring the First Customer 33:27 - Tips for Seeking Funding 40:09 - Challenges as a Female Founder 43:43 - Integrating AI with the Platform 46:21 - Final Thoughts and Advice  Roupen Odabashian:  LinkedIn: https://www.linkedin.com/in/roupen-odabashian-183aaa142/X: https://twitter.com/RoupenMD Jyotsna Mehta LinkedIn: https://www.linkedin.com/in/jyotsna-mehta-905b413/ Keva Health LinkedIn: https://www.linkedin.com/company/kevahealth/ Learn More about: https://www.youtube.com/watch?v=eVza3B6v6iU Website: https://www.kevahealth.com Publications: https://www.kevahealth.com/wp-content/uploads/2023/01/RPM-Asthma-CHEST-2022.pdf 

The human gut microbiome, a vast community of trillions of bacteria, profoundly influences health by closely interacting with our diet. Despite increased research in the past decade linking gut bacteria to various health aspects, translating this knowledge into practical benefits has been challenging due to the microbiome's complexity. Jona, led by health technology and AI expert Leo Grady, is at the forefront of this effort. Their innovative AI technology analyzes individual microbiome profiles, interprets data, and synthesizes scientific understanding, providing personalized insights to help individuals understand and improve their health at a fundamental level, alleviate symptoms, and prevent chronic diseases.  Join us today as we delve into this fascinating topic with Leo Grady, whose expertise at Jona is unlocking new understandings of the gut microbiome's impact on our health.  This Episode is brought to you by MeshAIhttps://welcome.meshai.io For sponsoring future episodes, please email us at roupen@deltahealth.techTime stamps:  02:47 - Introduction to Jona's Inception06:33 - Jona's Unique Technology09:46 - Jona and the FDA13:47 - Understanding the Costs15:08 - The Inspiration Behind Jona19:13 - Learning from Mistakes24:18 - Team Building and Hiring Insights26:20 - Mentorship and Personal Growth29:17 - Strategies for Scaling Jona Roupen Odabashian:  LinkedIn: https://www.linkedin.com/in/roupen-odabashian-183aaa142/ X: https://twitter.com/RoupenMD   Leo Grady LinkedIn: https://www.linkedin.com/in/leo-grady-a745517/ X: htps://twitter.com/lgrady00Jonas website: https://jona.health/ LinkedIn: https://www.linkedin.com/company/jona-health/about/Instagram: https://www.instagram.com/jonahealth/ 

Welcome to today's episode of our podcast, where we dive into the intricate world of intellectual property and innovation. Joining us is a distinguished guest, Peter Fasse, a seasoned patent attorney from the renowned law firm Fish & Richardson.Peter's expertise lies at the intersection of law and cutting-edge technology. He has dedicated his career to guiding clients through the complex landscape of patent prosecution, specializing in a myriad of fields including biotechnology, healthcare, medical devices, and an array of green technologies. His proficiency extends to assisting a diverse range of clients, from ambitious startups to established multinationals, in crafting competitive global patent strategies and building robust, defensible patent portfolios.Peter is a principal at Fish & Richardson, a global leader in intellectual property law. This firm, established in 1878, is renowned for its comprehensive services in litigation, prosecution, post-grant review proceedings, and counseling for patents, trademarks, copyrights, and trade secrets. Fish has more than 450 attorneys and technology specialists across the U.S., Europe, and China.This Episode is brought to you by MeshAIhttps://welcome.meshai.ioFor sponsoring future episodes please email roupen@deltahealth.techTime stamps:00:00 - Introduction02:45 - Defining Patents in HealthTech: Types and Importance08:38 - Costs of Obtaining Patents for HealthTech Startups25:55 - Protecting IP During FDA Approval Process33:54 - Patentability of Medical AI and AI Algorithms37:47 - Challenges and Pitfalls in the HealthTech Patenting Process51:07 - Advice for Physician Entrepreneurs and HealthTech Founders on PatentYouTube: https://youtu.be/miRx79nIyioRoupen Odabashian:LinkedIn: https://www.linkedin.com/in/roupen-odabashian-183aaa142/X: https://twitter.com/RoupenMDFor sponsorships please Email: roupen@deltahealth.techPeter FasseLinkedIn: https://www.linkedin.com/in/peter-fasse-2207911/Website and contact: https://www.fr.com/team/j-peter-fasse/Fish & Richardson:LinkedIn: https://www.linkedin.com/company/fish-&-richardson-p-c-/Website: https://www.fr.com/

Cancer, one of the most lethal diseases of the twenty-first century, continues to challenge the medical community. Conventional treatments like chemotherapy and radiation can be effective, but they often come with many side effectsNow Imagine tiny robots, meticulously designed, capable of targeting cancer cells at their very core – the DNA. These nanobots offer a level of precision in treatment that traditional methods can't match, potentially reducing the need for harsh chemotherapy and radiation. This is not a dream, but it is true due to companies like DNA Nanobots.However, the potential of DNA nanobots extends far beyond the treatment of cancer. They could be engineered to detect specific molecules or markers associated with various diseases, leading to earlier and more accurate diagnoses. Today we talk to Chris Lucas, the Chief Science Officer of DNA Nanobots. With a deep-seated background in technology commercialization and DNA nanotechnology, Chris is not just riding the wave of innovation – he's helping to create it.Join us today on Delta, as we dive into the exciting and rapidly evolving world of DNA Nanobots.This Episode is brought to you by MeshAI https://welcome.meshai.ioMeshAI is a scheduling software for healthcare workers, including medical students, residents, physicians, and nurses, it alleviates administrative burdens by leveraging AI algorithms for scheduling shifts. MeshAI automates the creation of equitable schedules, efficiently assigns the most suitable staff for each shift, and facilitates easy shift trading among healthcare professionals. MeshAI is more than just a scheduling tool; it's specifically designed to cater to the unique training requirements of each residency program. Time stamps:00:00 - Introduction02:00 - What are DNA Nanobots, how do they work, and where is the technology currently?05:24 - Applications of DNA Nanobots technology.07:59 - Personal journey into the DNA Nanobots space and the motivation for starting the company.24:55 - DNA Nanobots' distinctiveness in the crowded field of nanotechnology in medicine.29:48 - The role of artificial intelligence in enhancing DNA Nanobots technology and its development.34:51 - Current treatments approved using DNA Nanobots technology.36:23 - Approach to FDA approval and challenges in regulatory compliance for medical technologies.37:33 - Challenges in innovating within the biotech space.48:39 - Personal motivation and ultimate goals for DNA Nanobots.Find us on YouTube: https://youtu.be/ChYP7muspicRoupen Odabashian:LinkedIn: https://www.linkedin.com/in/roupen-odabashian-183aaa142/ X: https://twitter.com/RoupenMDFor sponsorships please Email: roupen@deltahealth.techChristopher Lucas, Ph.D.LinkedIn: https://www.linkedin.com/in/chrislucasdnananobots/DNANanobots website:https://dnananobots.com/

Tremor is a common movement disorder characterized by involuntary, rhythmic muscle contractions that lead to shaking movements in one or more parts of the body. It is most commonly seen in the handsThe impact of a tremor on an individual's life can be significant. It can interfere with daily activities like writing, drinking, eating, or using a phone or computer. This not only affects physical abilities but can also have emotional and social repercussions. People with tremors may experience frustration, embarrassment, and even social isolation due to the challenges they face.There are various types of tremors, each with its own characteristics and causesTraditional treatment options include medications such as beta-blockers or antiepileptic drugs for essential tremors, and Parkinson's disease treatments often involve dopamine-enhancing drugs. In more severe cases, surgical interventions like deep brain stimulation are considered.However, we will talk about SteadiWear. A company that is at the forefront of an innovative approach to managing these tremors. Unlike medication or surgery, which can have significant side effects or involve invasive procedures, SteadiWear develops non-invasive devices designed to provide immediate tremor stabilization.Without further due lets talk to the CEOs of SteadiWear.For sponsorships please Email: roupen@deltahealth.techTime stamps:02:04 - Introduction to Steadiwear: The Beginning of a Journey05:48 - The Role of Startup Accelerators in Steadiwear's Growth08:19 - Overcoming Obstacles: Setbacks and Strategic Pivots12:39 - Behind the Technology: How Steadiwear Operates16:44 - Navigating Regulatory Approvals in MedTech22:11 - Marketing Strategies in the Healthcare Sector26:14 - The Process of Creating Healthcare Products33:34 - Challenges in Securing Funding for Healthcare Innovations41:39 - User and Physician Feedback: Insights and Impacts45:29 - Looking Ahead: Future Plans for Steadiwear48:21 - Strategies for Scaling Up in the Health Tech Industry49:11 - Expert Advice for Aspiring MedTech EntrepreneursYouTube: https://youtu.be/Bjub-lCWx1MRoupen OdabashianLinkedIn: https://www.linkedin.com/in/roupen-odabashian-183aaa142/X: https://twitter.com/RoupenMDMark EliasLinkedIn: https://www.linkedin.com/in/mark-elias-11a7506a/Emile Maamary:LinkedIn: https://www.linkedin.com/in/emile-maamary/SteadiWearWebsite: https://steadiwear.comLinkedIn: https://www.linkedin.com/company/steadiwear-inc-/X: https://twitter.com/steadiwear

Pathology is the study of cells under a microscope, it is a critical field in healthcare, particularly in cancer diagnosis. However, a significant challenge in pathology is the inconsistency in reports and occasional disagreement between pathologists. This can lead to variations in cancer diagnosis and treatment, impacting patient care. To address these critical issues, One such groundbreaking approach is the integration of Artificial Intelligence (AI) in pathology, which is Pioneered by companies like PaigeAI. PaigeAI, is a company in the field of digital diagnostics, they are using next-generation computational technology, machine learning, and artificial intelligence to revolutionize cancer diagnosis. PaigeAI's platform and AI applications, including the Paige Prostate Suite and Paige Breast Suite, have been instrumental in streamlining pathology workflows. They provide actionable diagnostic insights that directly affect patient care. With their solutions, they have shown a remarkable 70% reduction in cancer detection errors and a substantial decrease in the time taken for diagnosis. As the first company to receive FDA approval for an AI application in pathology, PaigeAI has set a new standard in the field. Join me today as we talk to Dr. Moye the CEO of PaigeAI Time stamps: 1:33 AI in Cancer Care: Revolutionizing Diagnosis 4:25 Improving Cancer Diagnostics with AI and Machine Learning 10:45 The Role of AI in Predicting Biomarkers and Treatment Responses 24:28 Navigating Healthcare Economics: The Path to AI Integration 34:01 Measures does Paige.AI take to ensure the accuracy of its results 38:44 Every test has its limitations 40:33 Personal Journey: From Science to AI-Driven Healthcare Entrepreneurship 43:41 Challenges of integrating AI in pathology 47:20 Building Teams for Healthcare Innovation: Bridging Technology and Medicine YouTube: https://youtu.be/eqsZduM_4skRoupen Odabashian: LinkedIn: https://www.linkedin.com/in/roupen-odabashian-183aaa142/ X: https://twitter.com/RoupenMD For sponsorships please Email: roupen@deltahealth.tech Andy Moye, PhD LinkedIn: https://www.linkedin.com/in/andymoye/ Paige.AI Website: https://paige.ai X: https://twitter.com/paige_ai

Today's episode is part 2 of my interview with Prof. Shahram Yousefi, the CEO of Mesh AI.Mesh AI is a groundbreaking platform designed to revolutionize healthcare scheduling, addressing a critical challenge in the industry: clinician burnout. By leveraging advanced algorithms and user-friendly interfaces, Mesh AI enables seamless, one-click scheduling for healthcare providers. This innovative approach not only saves time but also empowers clinicians with more control and flexibility over their schedules, leading to improved work-life balance and overall job satisfaction.Join me today as we talk about navigating fundraising challenges in healthcare, the importance of Mentorship, and insights gained from Shahram's journey.Find this episode on YouTube: https://youtu.be/Tk5UP8SgcLoTime stamps:2:36 Navigating Fundraising Challenges in the HealthTech Industry6:51 The Pursuit of Mentorship for Beginners in HealthTech10:35 Insights Gained: What I Wish I Knew at the Start of My HealthTech Journey13:43 Strategies for Persuading Hospitals to Invest in Your HealthTech Product21:40 Final Thoughts and TakeawaysRoupen Odabashian:LinkedIn: https://www.linkedin.com/in/roupen-odabashian-183aaa142/X: https://twitter.com/RoupenMDEmail: roupen.odabashian@hotmail.comShahram (Sean) YousefiLinkedIn: https://www.linkedin.com/in/shahramy/X: https://twitter.com/profyousefiwebsite: https://welcome.meshai.io/Today's Episode Sponsors:Supportful: Find Top talented software engineers that can help you with many aspects of your projectLinkedIn: https://www.linkedin.com/company/supportful-world/Website: https://www.supportful.world/

In today's episode, I had the honor of interviewing Prof. Shahram Yousefi, the CEO of Mesh AI.Mesh AI is a groundbreaking platform designed to revolutionize healthcare scheduling, addressing a critical challenge in the industry: clinician burnout. By leveraging advanced algorithms and user-friendly interfaces, Mesh AI enables seamless, one-click scheduling for healthcare providers. This innovative approach not only saves time but also empowers clinicians with more control and flexibility over their schedules, leading to improved work-life balance and overall job satisfaction.Join me today as we delve into the intricacies of healthcare scheduling and talk to Dr. Yousefi’s advice on switching from academia to entrepreneurship and building great teamsTime stamps:3:22 - The Genesis of MeshAI: Unraveling the Origin Story5:49 - Behind the Brand: The Story Behind MeshAI's Name7:46 - Exploring MeshAI: Understanding Its Core Functions and Services12:51 - Future Horizons: Envisioning MeshAI's Evolution and Impact19:43 - The Shift from Academic Research to Entrepreneurship24:55 - The Art of Team Building: Strategies for Recruiting in a Startup EnvironmentYouTube Linke: https://youtu.be/U1gWijtyLzgRoupen Odabashian:LinkedIn: https://www.linkedin.com/in/roupen-odabashian-183aaa142/X: https://twitter.com/RoupenMDEmail: roupen@deltahealth.techShahram (Sean) YousefiLinkedIn: https://www.linkedin.com/in/shahramy/X: https://twitter.com/profyousefiwebsite: https://welcome.meshai.io/Today's Episode Sponsors:Supportful: Find Top talented software engineers that can help you with many aspects of your projectLinkedIn: https://www.linkedin.com/company/supportful-world/Website: https://www.supportful.world/#MeshAI, #HealthcareInnovation, #ClinicianWellbeing, #HealthcareScheduling, #TechInHealthcare, #BurnoutPrevention, #HealthcareManagement, #DigitalHealth, #HealthcareTech, #EmployeeSatisfaction, #WorkLifeBalance, #HealthcareSolutions, #PatientCare, #StressManagement, #HealthcareIndustry